Imunon Inc. (NASDAQ: IMNN)
$0.8100
+0.1170 ( +17.39% ) 232.3K
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
Market Data
Open
$0.8100
Previous close
$0.6930
Volume
232.3K
Market cap
$11.66M
Day range
$0.6780 - $0.8250
52 week range
$0.4800 - $3.6500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 75 | Nov 07, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
4/a | Other | 2 | Oct 31, 2024 |
4 | Insider transactions | 1 | Oct 08, 2024 |
3 | Insider transactions | 1 | Oct 07, 2024 |
8-k | 8K-related | 18 | Oct 07, 2024 |
4 | Insider transactions | 1 | Sep 10, 2024 |
4 | Insider transactions | 1 | Sep 10, 2024 |
4 | Insider transactions | 1 | Sep 10, 2024 |
4 | Insider transactions | 1 | Sep 10, 2024 |